Results

Total Results: 1,098 records

Showing results for "evaluating".

81. Final Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-kidney-disease-screening
    July 13, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Chronic Kidney Disease: Screening July 13, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They should no…

82. Chemoprevention of Breast Cancer - Recommendations and Rationale (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
    July 02, 2002 - anti-estrogen properties (a selective estrogen receptor modulator).4 A meta-analysis of 55 studies evaluating … were more likely to be taking hormone replacement therapy or to have had an oopherectomy.1 The study evaluating

83. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/eko8Cp28pZ3SHHfyvTXJW5
    May 13, 2025 - Unclear applicability of study body, which comes from studies conducted in China One observational study evaluating

84. Archived: Skin Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening-july-2016
    July 26, 2016 - studies on the test characteristics of the clinical visual skin examination have been published: 1 evaluating … screening performed by primary care clinicians and 1 evaluating screening performed by dermatologists … in melanoma mortality were observed among both men and women. 15 Furthermore, an independent study evaluating

85. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast … Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane

86. Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
    February 11, 2025 - For KQ4 and KQ5, RCTs or controlled cohort studies (for harms only) evaluating US Food and Drug Administration … For predictive accuracy of studies evaluating risk assess- ment instruments, the ROB of each instrument … In women, AUCs ranged from 0.32 to 0.87 across 35 articles evaluating 11 instru- ments (eFigure 5 in … As in the prior report, the SOE is in- sufficient for evaluating the effect of treatment on very rare … Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older

87. Archived: Final Research Plan: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan35/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
    November 15, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening November 15, 2013 Recommendations made by the USPSTF are indepe…

88. Final Research Plan: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/autism-spectrum-disorder-young-children-1
    June 10, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Autism Spectrum Disorder in Young Children: Screening June 10, 2021 Recommendations made by the USPSTF are independent of the U.S. govern…

89. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast … Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane

90. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zHvENvrSUeZh6gFPUK_37c
    February 13, 2018 - In addition, studies evaluating the ben- efits and harms of these screening strategies in asymptomatic … Effectiveness of Screening The USPSTF reviewed direct evidence evaluating the benefits of screening for … ovarian cancer on mortality.3 The USPSTF identified 3 good-quality studies evaluating the effect of

91. U.S. Preventive Services Task Force Standards for Guideline Development (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/standards-guideline-dev%20(1).pdf
    September 06, 2019 - These calls and meetings often include discussions about the methodological issues related to evaluating

92. Convergence and Divergence Around Breast Cancer Screening: Editorial (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/bJo9H35qzP9xT2qsH8cMwk
    February 01, 2016 - coverage es- tablished by the Patient Protection and Affordable Care Act, the USPSTF's role is limited to evaluating

93. Nominate a Recommendation Statement Topic | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominate-recommendation-statement-topic
    April 01, 2019 - Nominate a Recommendation Statement Topic Share to Facebook Share to X Share to WhatsApp Share to Email Print Anyone - including individuals and organizations - can nominate a topic for the U.S. Preventive Services Task Force (USPSTF) to cons…

94. Clinical Summary: Screening for Ovarian Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/gGt88ZDJVoaNx_UZ-yMnyk
    Clinical Summary: Screening for Ovarian Cancer Clinical Summary: Screening for Ovarian Cancer Population Asymptomatic women without a known high-risk hereditary cancer syndrome Recommendation Do not screen for ovarian cancer in asymptomatic women. Grade: D Risk Assessment Women with certain…

95. Recommendation: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening
    February 25, 2020 - Physician recognition of cognitive impairment: evaluating the need for improvement.

96. Evidence Summary: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-for-prediabetes-and-type-2-diabetes
    August 24, 2021 - Study Selection: English-language controlled studies evaluating screening or interventions for prediabetes … This review included 5 RCTs (described in 8 articles) evaluating interventions for recently diagnosed … Most trials evaluating hypoglycemic agents found no statistically significant association with changes … Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular … Delaying or Preventing Progression to Diabetes: Results of Meta-Analyses of Trials Evaluating Interventions

97. Evidence Summary: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/sexually-transmitted-infections-behavioral-counseling
    August 18, 2020 - Other reviews that have focused on different settings, study designs, and populations in evaluating STI … It is encouraging that there were new studies evaluating low– and moderate–contact time interventions … Evaluating a brief, video-based sexual risk reduction intervention and assessment reactivity with STI … Evaluating personalized feedback intervention framing with a randomized controlled trial to reduce young … Evaluating a culturally tailored HIV risk reduction intervention among Hispanic women delivered in a

98. VitaminD, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Yc24U4wMLXGoqE5NjwRVA6
    April 17, 2018 - Study Characteristics of Randomized Clinical Trials Evaluating the Effect of Vitamin D, Calcium, or Combined … No studies evaluating the effects of vitamin D alone on incident kidney stones were identified. … consistent with the find- ings of the prior review on behalf of the USPSTF,5 since only 2 new studies evaluating … Stud- ies evaluating harms varied in specificity of definition or rigor of harm outcome ascertainment … 0.80 (95% CI, 0.63 to 1.00). b One RCT was identified that was registered with a primary study aim of evaluating

99. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
    July 20, 2021 - Although studies evaluating stool-based tests using USPSTF Review: Screening for Colorectal Cancer US … No studies were found evaluating the effectiveness of CT colonography, high-sensitivity gFOBT, sDNA with … Colonoscopy Two large, prospective observational studies37,47 (n = 436 927) evaluating the association … Several adequately powered studies currently underway are evaluating the comparative effec- tiveness … Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.

100. Archived: Letter to the Editor and Response from the Evidence-Based Practice Center: Human Papillomavirus Testing to Screen for Cervical Cancer: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/letter-to-the-editor-and-response-from-the-evidence-based-practice-center--human-papillomavirus-testing-to-screen-for-cervical-cancer/cervical-cancer-screening-2012
     February 15, 2012 - For example, masking patients is plausibly irrelevant when evaluating preventive programs where patient